Page last updated: 2024-10-17

n(1)-methylnicotinamide and Fatty Liver

n(1)-methylnicotinamide has been researched along with Fatty Liver in 1 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lai, S1
Ma, Y1
Hao, L1
Ding, Q1
Chang, K1
Zhuge, H1
Qiu, J1
Xu, T1
Dou, X1
Li, S1

Other Studies

1 other study available for n(1)-methylnicotinamide and Fatty Liver

ArticleYear
1-Methylnicotinamide promotes hepatic steatosis in mice: A potential mechanism in chronic alcohol-induced fatty liver disease.
    Biochimica et biophysica acta. Molecular and cell biology of lipids, 2023, Volume: 1868, Issue:4

    Topics: Animals; Chronic Disease; Ethanol; Fatty Liver; Fatty Liver, Alcoholic; Mice; Mice, Inbred C57BL; St

2023